XML 87 R72.htm IDEA: XBRL DOCUMENT v3.26.1
License, Collaboration, and Other Arrangements - ESSA arrangement and Sale of Future Revenue Streams (Details)
$ in Thousands
12 Months Ended
Oct. 09, 2025
USD ($)
Dec. 21, 2016
USD ($)
agreement
period
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Oct. 31, 2025
USD ($)
Oct. 08, 2025
Acquisitions, Licensing and Other Arrangements            
Payment to issue short-term loan to Xeno     $ 5,877      
Receipt from short-term loan repayment by Xeno     5,877      
Unearned revenue recognized under units-of-revenue method     (1,310) $ (3,570)    
Revenue recognized under units-of-revenue method     1,310 3,570    
Unearned revenue recognized under units-of-revenue method, current     1,268 1,361    
Unearned revenue recognized under units-of-revenue method, noncurrent     3,193 4,410    
Essa Pharma Inc | BVF | Investor            
Acquisitions, Licensing and Other Arrangements            
Ownership interest (as a percent)           24.70%
HealthCare Royalty Partners II, L.P. | Royalty Sale Agreements            
Acquisitions, Licensing and Other Arrangements            
Number of agreements | agreement   2        
Unearned revenue recognized under units-of-revenue method   $ 18,000        
Revenue recognized under units-of-revenue method     1,300 3,600    
Unearned revenue recognized under units-of-revenue method, current     1,300 1,400    
Unearned revenue recognized under units-of-revenue method, noncurrent     $ 3,200 $ 4,400    
HealthCare Royalty Partners II, L.P. | First Royalty Sale Agreement            
Acquisitions, Licensing and Other Arrangements            
Cash payment received   6,500        
Eligible potential additional payments receivable upon achievement of specified net sales milestones in future years   $ 4,000        
Number of milestone periods | period   3        
HealthCare Royalty Partners II, L.P. | Second Royalty Sale Agreement            
Acquisitions, Licensing and Other Arrangements            
Cash payment received   $ 11,500        
Xeno            
Acquisitions, Licensing and Other Arrangements            
Acquisition service, arranger fee, receivable         $ 3,000  
Payment to issue short-term loan to Xeno $ 5,900          
Receipt from short-term loan repayment by Xeno $ 5,900